In a strikingly blunt briefing, a…
In a strikingly blunt briefing, a senior FDA official accused [...]
Merck KGaA is no longer pursuing…
Merck KGaA is no longer pursuing clinical-stage candidates obtained through [...]
Flagship Pioneering-backed Alltrna…
Flagship Pioneering-backed Alltrna is once again laying off staff, this [...]
The back-and-forth between the FDA…
The back-and-forth between the FDA and gene therapy developer uniQure [...]
Cardiovascular biotech Tenaya…
Cardiovascular biotech Tenaya Therapeutics has signed a research collaboration agreement [...]
After steering positive key…
After steering positive key pivotal readouts for a trio of [...]
Roche is plugging 710 billion won…
Roche is plugging 710 billion won (about $484 million) into [...]
Bayer has discontinued an…
Bayer has discontinued an early-stage clinical gene therapy for a [...]
The FDA has released the rejection…
The FDA has released the rejection letter explaining its recent [...]
Theravance Biopharma will lay off…
Theravance Biopharma will lay off 50% of its workforce, end [...]